Cardiovascular Division, School of Life Science and Medicine, King's College London, London, UK
Cardiovascular Division, School of Life Science and Medicine, King's College London, London, UK.
Open Heart. 2021 Jun;8(1). doi: 10.1136/openhrt-2020-001496.
Durability of transcatheter aortic valve implantation (TAVI) is key to its expansion. We sought to identify incidence of valve thrombosis and predictors of valve thrombosis in our single centre with associated coagulation testing pre-TAVI and post-TAVI.
This single-centre observational study comprised patients undergoing transfemoral TAVI discussed in the Heart Team meeting . Patients were followed up with echocardiography at 120 days to identify incidence of elevated transvalvular gradient and multivariable analysis was performed to identify factors associated with an increased odds of developing valve thrombosis. In addition, 11 patients underwent baseline, day 1 and day 120 post-TAVI coagulation testing. Between August 2017 and August 2019, 437 consecutive patients underwent transfemoral TAVI. Of these patients, 207/437 (47.4%) had 3-month follow-up echo data available and were analysed. Of these patients, 26/207 (12.6%) had elevated transvalvular gradients. These patients tended to be younger (80±14 vs 83±6 years; p=0.047) with a lower ejection fraction (49±13 vs 54%±11%; p=0.021), with a greater proportion of the population experiencing atrial fibrillation (14/21, 54% vs 68/181, 38%; p=0.067). Following multivariable analysis, there remained a trend towards higher eccentricity index associated with elevated gradients. Baseline (pre-TAVI) elevation of thrombin antithrombin levels (56±63; reference range 1.0-4.1 ng/L) and PF 1+2 (791±632; reference range 69-229 ng/mL) normalised at 120 days post-TAVI CONCLUSION: This study demonstrated that in the cohort of patients undergoing transfemoral TAVI in our centre: younger age, poor ejection fraction, atrial fibrillation and increased baseline eccentricity of the aortic valve annulus were present to a greater extent in patients exhibiting elevated transvalvular gradients at 3-month follow-up. Further work is required to delineate the extent of coagulation derangement and confirm predictors of thrombosis.
经导管主动脉瓣置换术(TAVI)的耐久性是其推广的关键。我们旨在确定我们中心 TAVI 术后的瓣膜血栓形成发生率,并对 TAVI 术前和术后的瓣膜血栓形成预测因素进行分析。
这项单中心观察性研究纳入了在心脏团队会议上讨论过的接受经股 TAVI 的患者。患者在 120 天时接受超声心动图随访,以确定跨瓣梯度升高的发生率,并进行多变量分析以确定与瓣膜血栓形成风险增加相关的因素。此外,11 例患者在 TAVI 术前、术后第 1 天和第 120 天进行了基线、第 1 天和第 120 天的凝血检测。2017 年 8 月至 2019 年 8 月,437 例连续患者接受经股 TAVI。其中 207/437(47.4%)例患者有 3 个月的随访超声数据可供分析。其中 26/207(12.6%)例患者跨瓣梯度升高。这些患者往往更年轻(80±14 岁比 83±6 岁;p=0.047),射血分数更低(49±13%比 54%±11%;p=0.021),心房颤动的发生率更高(14/21,54%比 68/181,38%;p=0.067)。多变量分析后,仍存在较高的偏心指数与升高的梯度相关的趋势。凝血酶抗凝血酶水平(56±63;参考范围 1.0-4.1ng/L)和 PF1+2(791±632;参考范围 69-229ng/mL)在基线(TAVI 术前)升高,在 120 天后恢复正常
本研究表明,在我们中心接受经股 TAVI 的患者队列中:在 3 个月随访时,跨瓣梯度升高的患者更年轻、射血分数更低、存在心房颤动和主动脉瓣环的基线偏心度增加。需要进一步的研究来阐明凝血紊乱的程度,并确认血栓形成的预测因素。